Product Information

PREGABALIN 50 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0479 per EA under NDC 67877046305. Its NADAC has been published 264 times since Nov 3, 2021.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 50 MG CAPSULE

Pregabalin
$0.0479per EA
DEA Schedule CV

Strength

50 mg/1

NDC

67877046305

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA207799

FDA Approved

7/19/2019

TE Code

AB

On Market Since

10/2/2019

Price Statistics

The NADAC for PREGABALIN 50 MG CAPSULE has been published 264 times since Nov 3, 2021, and over the history we have for it it has declined 46.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0479 per EA
All-time high$0.0937 (Jul 13, 2022)
All-time low$0.0398 (Nov 20, 2024)
52-week high$0.0498
52-week low$0.0459
Median price$0.0579
Average price$0.0619
Largest weekly change-37.6% (Nov 20, 2024)
Weeks tracked264
Tracking sinceNov 3, 2021

Price History

1W

+0.5%

1M

+1.8%

3M

+1.9%

6M

+4.5%

1Y

-3.8%

3Y

-16.2%

5Y

-44.3%

All

-46.3%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 50 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0479 per EA (NDC 67877046305), effective Nov 18, 2026.

How has the price of PREGABALIN 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 50 MG CAPSULE has declined 46.3%. It has been tracked across 264 weekly CMS publications since Nov 3, 2021.

What are the highest and lowest recorded NADAC prices for PREGABALIN 50 MG CAPSULE?

Since Nov 3, 2021, the NADAC for PREGABALIN 50 MG CAPSULE has ranged from a low of $0.0398 (Nov 20, 2024) to a high of $0.0937 (Jul 13, 2022), with a median of $0.0579 per EA.

Are there cheaper alternatives to PREGABALIN 50 MG CAPSULE?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 50 MG CAPSULE, is $0.0471 per EA — about 2% below PREGABALIN 50 MG CAPSULE.

Who manufactures PREGABALIN 50 MG CAPSULE?

PREGABALIN 50 MG CAPSULE (NDC 67877046305) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.